These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. New treatments for movement disorders? Fox SH; Brotchie JM Trends Pharmacol Sci; 1996 Oct; 17(10):339-42. PubMed ID: 8979766 [No Abstract] [Full Text] [Related]
8. Thalamic stimulation for control of movement disorders. Andy OJ Appl Neurophysiol; 1983; 46(1-4):107-11. PubMed ID: 6608315 [TBL] [Abstract][Full Text] [Related]
9. Coding for the use of botulinum toxin for movement disorders. Brashear A; Bushong L Continuum (Minneap Minn); 2013 Oct; 19(5 Movement Disorders):1406-15. PubMed ID: 24092297 [No Abstract] [Full Text] [Related]
10. Mesothalamic brain stimulation for movement disorders (functional ablation of mini-discharge circuits). Andy OJ Pavlov J Biol Sci; 1987; 22(1):40. PubMed ID: 3494224 [No Abstract] [Full Text] [Related]
12. [Resistance to treatment in movement disorders]. Vingerhoets FJ; Burkhard PR Rev Med Suisse; 2012 May; 8(339):926-9. PubMed ID: 22675821 [TBL] [Abstract][Full Text] [Related]
13. Orofacial Movement Disorders. Clark GT; Ram S Oral Maxillofac Surg Clin North Am; 2016 Aug; 28(3):397-407. PubMed ID: 27475514 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic extradural cortical stimulation for movement disorders: a review. Canavero S; Bonicalzi V; Paolotti R; Castellano G; Greco-Crasto S; Rizzo L; Davini O; Maina R Neurol Res; 2003 Mar; 25(2):118-22. PubMed ID: 12635508 [TBL] [Abstract][Full Text] [Related]
15. Functional brain imaging of movement disorders. Eidelberg D; Edwards C Neurol Res; 2000 Apr; 22(3):305-12. PubMed ID: 10769825 [TBL] [Abstract][Full Text] [Related]
16. Movement Disorders and Voice. Snow G; Guardiani E Otolaryngol Clin North Am; 2019 Aug; 52(4):759-767. PubMed ID: 31076164 [TBL] [Abstract][Full Text] [Related]
17. Clinical application of transcutaneous electrical nerve stimulation and high cervical cord stimulation for movement disorders. Lamb S J Neurosurg Nurs; 1983 Feb; 15(1):1-4. PubMed ID: 6601695 [No Abstract] [Full Text] [Related]
18. Mechanisms and the current state of deep brain stimulation in neuropsychiatry. Greenberg BD; Rezai AR CNS Spectr; 2003 Jul; 8(7):522-6. PubMed ID: 12894033 [TBL] [Abstract][Full Text] [Related]
19. Introduction: the importance of cognition in movement disorders. Burn D; Weintraub D; Robbins T Mov Disord; 2014 Apr; 29(5):581-3. PubMed ID: 24757107 [No Abstract] [Full Text] [Related]
20. Therapeutic use of type F botulinum toxin. Ludlow CL; Hallett M; Rhew K; Cole R; Shimizu T; Sakaguchi G; Bagley JA; Schulz GM; Yin SG; Koda J N Engl J Med; 1992 Jan; 326(5):349-50. PubMed ID: 1728750 [No Abstract] [Full Text] [Related] [Next] [New Search]